7222921
SARS-CoV-2 Spike RBD LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™
Llama Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Spike RBD
Dilution
Blockade of Receptor-ligand Interaction 50 ug/mL
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Purification Method
Protein A or G purified from cell culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone
L009.1.32H
Applications
Blocking Assay
Conjugate
Unconjugated
Host Species
Llama
Target Species
SARS-CoV-2
Gene Accession No.
YP_009724390.1
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Related Products
Description
- Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples
- It is validated for Blocking Assay
Compare Similar Items
Show Difference
Antigen: Spike RBD
Dilution: Blockade of Receptor-ligand Interaction 50 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone: L009.1.32H
Applications: Blocking Assay
Conjugate: Unconjugated
Host Species: Llama
Target Species: SARS-CoV-2
Gene Accession No.: YP_009724390.1
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Spike RBD
Dilution:
Blockade of Receptor-ligand Interaction 50 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone:
L009.1.32H
Applications:
Blocking Assay
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
SARS-CoV-2
Gene Accession No.:
YP_009724390.1
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: Siglec-3/CD33
Dilution: Flow Cytometry 0.25 ug/10^6 cells
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen: Mouse myeloma cell line NS0-derived human Siglec-3/CD33, Asp18--His259, Accession # AAA51948
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone: L008.2.25H
Applications: Flow Cytometry
Conjugate: Unconjugated
Host Species: Llama
Target Species: Human
Gene Accession No.: AAA51948
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Siglec-3/CD33
Dilution:
Flow Cytometry 0.25 ug/10^6 cells
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen:
Mouse myeloma cell line NS0-derived human Siglec-3/CD33, Asp18--His259, Accession # AAA51948
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone:
L008.2.25H
Applications:
Flow Cytometry
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
Human
Gene Accession No.:
AAA51948
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: Siglec-3/CD33
Dilution: Flow Cytometry 0.25 ug/10^6 cells
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen: Mouse myeloma cell line NS0-derived human Siglec-3/CD33 protein as immunogen for bivalent Llama VHH-Llama IgG2 Fusion Antibody, Asp18-His259, Accession # AAA51948
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone: L008.2.25LL
Applications: Flow Cytometry
Conjugate: Unconjugated
Host Species: Llama
Target Species: Human
Gene Accession No.: AAA51948
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Siglec-3/CD33
Dilution:
Flow Cytometry 0.25 ug/10^6 cells
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Immunogen:
Mouse myeloma cell line NS0-derived human Siglec-3/CD33 protein as immunogen for bivalent Llama VHH-Llama IgG2 Fusion Antibody, Asp18-His259, Accession # AAA51948
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone:
L008.2.25LL
Applications:
Flow Cytometry
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
Human
Gene Accession No.:
AAA51948
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: IL1RAPL2
Dilution: Immunohistochemistry 5-25 ug/mL
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Immunogen: Mouse myeloma cell line NS0-derived recombinant human IL-1 RAPL2, Thr17-Glu356, Accession # Q9NP60
Purification Method: Protein A or G purified from hybridoma culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone: 167720
Applications: Immunohistochemistry
Conjugate: Unconjugated
Host Species: Mouse
Target Species: Human
Gene Accession No.: Q9NP60
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
IL1RAPL2
Dilution:
Immunohistochemistry 5-25 ug/mL
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Immunogen:
Mouse myeloma cell line NS0-derived recombinant human IL-1 RAPL2, Thr17-Glu356, Accession # Q9NP60
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Clone:
167720
Applications:
Immunohistochemistry
Conjugate:
Unconjugated
Host Species:
Mouse
Target Species:
Human
Gene Accession No.:
Q9NP60
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.